Skincare solution start-up, SkinQ Dermo cosmetics has secured a seed investment led by Inflection Point Ventures with participation from Venture catalysts and Super Angels.    

The seed capital from IPV is pivotal for SkinQ's aggressive expansion plans, the stat-up added in a release.   

The funds will be strategically channelled towards launching innovative products, ramping up research and development, expanding the team, and enhancing the brand’s market presence, the company said.    
  
Ivy Chin, Partner, Inflection Point Ventures, says, “By embracing the melanin-rich skin of Indians, SkinQ aims to revolutionise skincare by recognizing the unique needs of Indians . By addressing the distinct requirements of the melanin-rich skin, SkinQ has the potential to captivate the hearts of millions, who can truly appreciate the difference in its products.”  

The start-up has achieved a significant operational milestone, growing MOM in their revenues, marking substantial growth and success in its endeavours with a discerning customer base and new channels of distribution. SkinQ is the first Indian Origin Dermo Cosmetics brand retailing in Dermatology offices and MedSpas in USA, it said.    

Dr. Chytra Anand, founder of SkinQ, says, “This capital infusion is pivotal in augmenting our research and development bandwidth, enriching our bespoke product portfolio, and amplifying our outreach to a discerning customer base. We are building a multi-dimensional approach to be present at various touch points of our customers skin health journey in the fasting growing segment today.”  

The Dermo Cosmetics market in India showed substantial growth, rising from $188 million in 2021 to an anticipated $450 million by 2030, indicating a significant upward trajectory. Globally, the industry was valued at $51 billion in 2021, forecasted to reach an impressive $130 billion by 2030, showcasing substantial expansion and potential for the coming years.